What is the maximum recommended daily dose of dapagliflozin and metformin (500 mg tablets)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Maximum Dose of Dapagliflozin and Metformin

The maximum recommended daily dose is dapagliflozin 10 mg once daily plus metformin 2000 mg per day (divided as 1000 mg twice daily). 1

Dapagliflozin Dosing

  • Standard maximum dose: 10 mg once daily for all approved indications including glycemic control, chronic kidney disease, and heart failure 1
  • Starting dose for glycemic control: 5 mg once daily, which can be increased to 10 mg if additional glucose lowering is needed 1
  • No higher dose provides additional clinical benefit - the 10 mg dose is the ceiling for both efficacy and cardiovascular/renal protection 2, 3

Metformin Dosing

  • Maximum dose: 2000-2500 mg per day depending on formulation 4
  • Typical dosing: 500-1000 mg twice daily with meals to minimize gastrointestinal side effects
  • Extended-release formulations may be titrated to the same maximum daily dose

Kidney Function Considerations

Critical dosing adjustments based on eGFR:

  • eGFR ≥45 mL/min/1.73 m²: Full doses of both medications can be used 2
  • eGFR 30-44 mL/min/1.73 m²:
    • Dapagliflozin 10 mg daily can continue 2
    • Metformin must be reduced to maximum 1000 mg/day 2
  • eGFR 25-29 mL/min/1.73 m²:
    • Dapagliflozin 10 mg can be initiated or continued for cardiovascular/renal benefit (not for glycemic control) 2, 5
    • Metformin is contraindicated 2
  • eGFR <25 mL/min/1.73 m²: Metformin absolutely contraindicated; dapagliflozin initiation not recommended but may continue if already established 2, 1

Clinical Combination Evidence

The combination of dapagliflozin plus metformin has been extensively studied and demonstrates superior glycemic control compared to either agent alone. In treatment-naïve patients with baseline HbA1c 7.5-12%, the combination achieved HbA1c reductions of approximately 2% versus 1.2-1.4% with monotherapy 6. Recent data confirm this combination is well-tolerated and effective across various patient populations 7, 8.

Important Safety Considerations

  • Monitor renal function regularly - at least annually when eGFR ≥60, every 3-6 months when eGFR 45-59, and more frequently when eGFR 30-44 9
  • Withhold dapagliflozin at least 3 days before major surgery to reduce ketoacidosis risk 1
  • Monitor for vitamin B12 deficiency with long-term metformin use (>4 years) 9
  • Adjust or discontinue metformin during acute illness or conditions predisposing to lactic acidosis

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.